Time to progression (TTP) is suggested as a reliable endpoint compared with the progression-free survival in the clinical trials of hepatocellular carcinoma (HCC). However, the correlation between TTP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback